Induction of anti-tumour immunity by dendritic cells transduced with hTERT recombinant adenovirus in mice

Journal of Pathology

Volumn 217, Issue 5, 2009, Pages 685-692

  Chen, Ling ^a   Tang, Xu Dong ^a   Yu, Song Tao ^a   Ai, Zhi Hua ^a   Fang, Dian Chun ^a   Cai, Yong Guo ^a   Luo, Yuan Hui ^a   Liang, Guang Ping ^a   Yang, Shi Ming ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Adenoviral vector; Cytotoxic t lymphocyte (CTL); Dendritic cells; Human telomerase reverse transcriptase (hTERT); Tumour vaccine

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; DENDRITIC CELL VACCINE; GAMMA INTERFERON; HLA A2 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TELOMERASE REVERSE TRANSCRIPTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER GENE THERAPY; CANCER IMMUNIZATION; CELL KILLING; CELL STRUCTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DRUG POTENCY; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR IMMUNITY; VIRAL GENE THERAPY; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; CANCER VACCINES; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; FEMALE; GENETIC VECTORS; HLA-A2 ANTIGEN; IMMUNOPHENOTYPING; INTERFERON-GAMMA; MICE; MICE, INBRED C57BL; T-LYMPHOCYTES, CYTOTOXIC; TELOMERASE; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 64549092429     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2493     Document Type: Article

References (32)

1. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245 - 252.
2. Steinman RM. Dendritic cells and immune-based therapies. Exp Hematol 1996;24:859-862.
3. Nair SK, Heiser A, Boczkowski D, Majumdar A, Naoe M, Lebkowski JS, et al. Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells. Nature Med 2000;6:1011-1017.
4. Vonderheide RH, Domchek SM, Schultze JL, George DJ, Hoar KM, Chen DY, et al. Vaccination of cancer patients against telomerase induces functional antitumor CD8+ T lymphocytes. Clin Cancer Res 2004;10:828-839.
5. Novellino L, Castelli C, Parmiani G. A listing of human tumor antigens recognized by T cells: March 2004 update. Cancer Immunol Immunother 2005;54:187-207.
6. Jager E, Ringhoffer M, Karbach J, Arand M, Oesch F, Knuth A. Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8+ cytotoxic-T-cell responses: evidence for immunoselection of antigen-loss variants in vivo. Int J Cancer 1996;66:470-476.
7. Yee C, Thompson JA, Roche P, Byrd DR, Lee PP, Piepkorn M, et al. Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of T cell-mediated vitiligo. J Exp Med 2000;192:1637- 1644.
8. Schultze JL, Maecker B, von Bergwelt-Baildon MS, Anderson KS, Vonderheide RH. Tumour immunotherapy: new tools, new treatment modalities and new T-cell antigens. Vox Sang 2001;80:81-89.
9. Collins K, Mitchell JR. Telomerase in the human organism. Oncogene 2002;21:564-579.
10. Hiyama E, Yamaoka H, Matsunaga T, Hayashi Y, Ando H, Suita S, et al. High expression of telomerase is an independent prognostic indicator of poor outcome in hepatoblastoma. Br J Cancer 2004;91:972-979.
11. Vonderheide RH, Hahn WC, Schultze JL, Nadler LM. The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes. Immunity 1999;10:673-679.
12. Minev B, Hipp J, Firat H, Schmidt JD, Langlade-Demoyen P, Zanetti M. Cytotoxic T cell immunity against telomerase reverse transcriptase in humans. Proc Natl Acad Sci U S A 2000;97:4796-4801.
13. Nakamura M, Iwahashi M, Nakamori M, Ueda K, Ojima T, Naka T, et al. Dendritic cells transduced with tumor-associated antigen gene elicit potent therapeutic antitumor immunity: comparison with immunodominant peptide-pulsed DCs. Oncology 2005;68:163-170.
14. Chen L, Liang GP, Tang XD, Chen T, Cai YG, Fang DC, et al. In vitro anti-tumor immune response induced by dendritic cells transfected with hTERT recombinant adenovirus. Biochem Biophys Res Commun 2006;351:927-934.
15. Chen T, Tang XD, Wan Y, Chen L, Yu ST, Xiong Z, et al. HLA-A2-restricted cytotoxic T lymphocyte epitopes from human heparanase as novel targets for broad-spectrum tumor immunotherapy. Neoplasia 2008;10:977-986.
16. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. JExp Med 1992;176:1693-1702.
17. Cai YG, Fang DC, Chen L, Tang XD, Chen T, Yu ST, et al. Dendritic cells reconstituted with a human heparanase gene induce potent cytotoxic T-cell responses against gastric tumor cells in vitro. Tumour Biol 2007;28:238-246.
18. Lycke NY, Coico RF. ELISPOT assay for measurement of antigen-specific and polyclonal antibody responses. In Current Protocols in Immunology, Coligan J (ed.). John Wiley: Hoboken, NJ, 1996; 7.14.1-7.14.7.
19. Tang XD, Wan Y, Chen L, Chen T, Yu ST, Xiong Z, et al.H-2Kb-restricted CTL epitopes from mouse heparanase elicit an anti- tumor immune response in vivo. Cancer Res 2008;68:1529-1537.
20. 51Cr-release assay to assess the cytotoxicity of dendritic cells on hematopoietic tumor cells. Immunol Invest 2003;32:219-227.
21. Steinman RM. Dendritic cells and the control of immunity: enhancing the efficiency of antigen presentation. Mt Sinai J Med 2001;68:160- 166.
22. Schreurs MW, Kueter EW, Scholten KB, Kramer D, Meijer CJ, Hooijberg E. Identification of a potential human telomerase reverse transcriptase-derived, HLA-A1-restricted cytotoxic T-lymphocyte epitope. Cancer Immunol Immunother 2005;54:703-712.
23. Dupont J, Latouche JB, Ma C, Sadelain M. Artificial antigen- presenting cells transduced with telomerase efficiently expand epitope-specific, human leukocyte antigen-restricted cytotoxic T cells. Cancer Res 2005;65:5417-5427.
24. Mizukoshi E, Nakamoto Y, Marukawa Y, Arai K, Yamashita T, Tsuji H, et al. Cytotoxic T cell responses to human telomerase reverse transcriptase in patients with hepatocellular carcinoma. Hepatology 2006;43:1284- 1294.
25. Adotevi O, Mollier K, Neuveut C, Cardinaud S, Boulanger E, Mignen B, et al. Immunogenic HLA-B*0702-restricted epitopes derived from human telomerase reverse transcriptase that elicit antitumor cytotoxic T-cell responses. Clin Cancer Res 2006;12:3158-3167.
26. Diebold SS, Cotten M, Koch N, Zenke M. MHC class II presentation of endogenously expressed antigens by transfected dendritic cells. Gene Ther 2001;8:487-493.
27. Kaplan JM, Yu Q, Piraino ST, Pennington SE, Shankara S, Wood- worth LA, et al. Induction of antitumor immunity with dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens. JImmunol 1999;163:699-707.
28. Mack CA, Song WR, Carpenter H, Wickham TJ, Kovesdi I, Harvey BG, et al. Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype. Hum Gene Ther 1997;8:99-109.
29. Su Z, Dannull J, Yang BK, Dahm P, Coleman D, Yancey D, et al. Telomerase mRNA-transfected dendritic cells stimulate antigen- specific CD8+ and CD4+ T cell responses in patients with metastatic prostate cancer. JImmunol 2005;174:3798-3807.
30. Vonderheide RH, Anderson KS, Hahn WC, Butler MO, Schultze JL, Nadler LM. Characterization of HLA-A3-restricted cytotoxic T lymphocytes reactive against the widely expressed tumor antigen telomerase. Clin Cancer Res 2001;7:3343-3348.
31. Su Z, Vieweg J, Weizer AZ, Dahm P, Yancey D, Turaga V, et al. Enhanced induction of telomerase-specific CD4(+) T cells using dendritic cells transfected with RNA encoding a chimeric gene product. Cancer Res 2002;62:5041-5048.
32. Frolkis M, Fischer MB, Wang Z, Lebkowski JS, Chiu CP, Majum- dar AS. Dendritic cells reconstituted with human telomerase gene induce potent cytotoxic T-cell response against different types of tumors. Cancer Gene Ther 2003;10:239-249.